Argan, O. Et Al. 2018. Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14 , 1067-1073.

Argan, O., Ural, D., KARAÜZÜM, K., Bozyel, S., Aktas, M., KARAÜZÜM, İ., ... Kozdag, G.(2018). Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14, 1067-1073.

Argan, Onur Et Al. "Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14, 1067-1073, 2018

Argan, Onur Et Al. "Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14, pp.1067-1073, 2018

Argan, O. Et Al. (2018) . "Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14, pp.1067-1073.

@article{article, author={Onur Argan Et Al. }, title={Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis}, journal={THERAPEUTICS AND CLINICAL RISK MANAGEMENT}, year=2018, pages={1067-1073} }